Skip to main content
. 2019 Dec 30;9(12):e025627. doi: 10.1136/bmjopen-2018-025627

Table 3.

Use of concomitant medications

Austria (n=86) Switzerland (n=52)
Patients receiving at least one concomitant medication, n (%) 31 (36.1) 13 (25.0)
 Renin–angiotensin system agents 7 (8.1) 6 (11.5)
 Psychoanaleptics 6 (7.0) 2 (3.9)
 Beta-blocking agents 4 (4.7) 4 (7.7)
 Lipid-modifying agents 4 (4.7) 4 (7.7)
 Psycholeptics 3 (3.5) 0
 Diabetes drugs 3 (3.5) 0
 Analgesics 0 3 (5.8)
 Drugs for acid-related disorders 0 2 (3.9)

Concomitant medications reported by anatomical main group.